Session J: Epidemiology, Modelling and Cost-Effectiveness
Tracks
.
Thursday, September 20, 2018 |
11:15 AM - 12:15 PM |
Sala II |
Speaker
Dr Zoe Ward
Senior Research Associate In Infectious Disease Modelling
University Of Bristol
The Cost-Effectiveness Of Undertaking HCV Treatment In Needle And Syringe Programmes In Tayside, Scotland
11:15 AM - 11:30 AMBiography
I am a mathematical biologist interested in infectious disease dynamics and epidemiology. I am currently working on models of hepatitis C virus in populations of people who inject drugs and the impact and cost effectiveness of harm reduction policies and treatment.
Dr Jack Stone
Senior Research Associate in Infectious Disease Modelling
University Of Bristol
Modelling The Impact Of Prevention And Treatment Interventions On Hiv And Hepatitis C Virus Transmission Among People Who Inject Drugs In Nairobi
11:30 AM - 11:45 AMBiography
Dr Jack Stone is a Senior Research Associate in infectious disease modelling at the Bristol Medical School, University of Bristol. His research focuses on the use of mathematical modelling to project the impact of interventions on transmission of hepatitis C virus and HIV among people who inject drugs.
Dr Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol
Cost-Effectiveness Of Scaling-Up Syringe Service Provision Among People Who Inject Drugs In Perry County, Kentucky
11:45 AM - 12:00 PMBiography
Has a PhD in mathematical biology and has been working at the University of Bristol since October 2014. At Bristol working on dynamic modelling of hepatitis C in people who inject drugs, modelling current intervention strategies and projecting the impact and cost-effectiveness of treatments and prevention interventions in the future.
Kostyantyn Dumchev
Scientific Director
Ukrainian Institute on Public Health Policy
Estimation Of The Number Of People Who Inject Drugs And Live With HIV And Viral Hepatitis Co-Infection In Ukraine
12:00 PM - 12:05 PMBiography
Dr Dumchev is a Scientific Director at the Ukrainian Institute on Public Health Policy. He conducts research in the areas related to substance use and HIV/AIDS, including epidemiology, estimation, and program effectiveness. Dr Dumchev received his MD from Vinnitsya National Medical University, and MPH from University of Alabama at Birmingham.
Ms Tetiana Mykhalchuk
Senior Programme Manager: Programmatic Monitoring & Evaluation And Donor Reporting
The International Charitable Foundation “Alliance for Public Health”
The Results of HIV and HCV Prevention Program among PWID in Ukraine
12:05 PM - 12:10 PMBiography
Tetiana Mykhalchuk is a Senior Programme Manager: Programmatic Monitoring & Evaluation and Donor Reporting (Alliance for Public Health) with 9 years experience in programmatic monitoring of prevention programs among vulnerable groups in Ukraine.
Prof Peter Vickerman
Professor of Infectious Disease Modelling
University Of Bristol
A Cost-Effective Strategy To Reach The WHO Hepatitis C Virus (HCV) Elimination Target In Men Who Have Sex With Men In The UK : A 90% Decrease In Hepatitis C Incidence By 2030
12:10 PM - 12:15 PMBiography
PhD Student, with work focused on the HIV and hepatitis C epidemic in men who have sex with men.
Chair
Natasha Martin
Associate Professor
University Of California, San Diego
Vana Sypsa
Professor Of Epidemiology And Medical Statistics
National And Kapodistrian University Of Athens